Short Term Visit (Scholarship)

1. Institute of Theoretical Chemistry, University of Vienna, Vienna, Austria (ASEA-UNINET scholarship)
2. College of Chemistry and Molecular Engineering, Peking University, Beijing, China (Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (CU-56-912-AM))

Awards

1. Outstanding poster presentation award, Pure and Applied Chemistry International Conference (PACCON), 2020
2. Outstanding Ph.D. research work, Ratchadapisek Sompot Fund, Chulalongkorn University, 2019
3. Outstanding poster presentation award, The 2018 Chemistry Research Symposium, ChRS2018, Kasetsart University, 2018
4. Outstanding academic performance with the highest GPAX (B.Sc. Student), The Professor Dr. Tab Nilanidhi Foundation, Faculty of Science, Chulalongkorn University, 2014

Selected Publications

1. P. Mahalapbutr, N. Kongtaworn, and T. Rungrotmongkol*, Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 nsp16/nsp10 RNA cap 2’-O-methyltransferase, Computational and Structural Biotechnology Journal, 2020, 18, 2757-2765. (IF 6.018)
2. P. Mahalapbutr, V. Sanghiran Lee, T. Rungrotmongkol*. Binding hotspot and activation mechanism of maltitol and lactitol toward the human sweet taste receptor, Journal of Agricultural and Food Chemistry, 2020, 68, 30, 7974-7983. (IF 4.192)
3. P. Mahalapbutr, M. Sangkhawasi, J. Kammarabutr, T. Rungrotmongkol, S. Chamni*. Rosmarinic acid as a potent influenza neuraminidase inhibitor: In vitro and in silico study, Current Topics in Medicinal Chemistry, 2020, 20(23), 2046-2055. (IF 3.218)
4. P. Mahalapbutr#, B. Nutho#, K. Hengphasatporn, NC. Pattaranggoon, N. Simanon, Y. Shigeta, S. Hannongbua*, T. Rungrotmongkol*, Why are lopinavir and ritonavir effective against the newly emerged coronavirus 2019? Atomistic insights into the inhibitory mechanisms, Biochemistry, 2020, 59(18), 1769-1779. (#First authors) (IF 2.952)
5. P. Mahalapbutr, P. Wonganan*, W. Chavasiri, N. Kungwan, T. Rungrotmongkol*, Butoxy mansonone G inhibits STAT3 and Akt signaling pathways in non-small cell lung cancers: Combined experimental and theoretical investigations, Cancers, 2019, 11, 437. (IF 6.162)
6. P. Mahalapbutr, N. Darai, W. Panman, A. Opasmahakul, N. Kungwan, S. Hannongbua, T. Rungrotmongkol*, Atomistic mechanisms underlying the activation of the G protein-coupled sweet receptor heterodimer by sugar alcohol recognition, Scientific Reports, 2019, 9, 10205. (IF 4.011)
7. P. Mahalapbutr, P. Wonganan, T. Charoenwongpaiboon, W. Chavasiri, T. Rungrotmongkol*. Enhanced solubility and anticancer potential of mansonone G by β-cyclodextrin-based host-guest complexation: A computational and experimental study, Biomolecules, 2019, 9, 545. (IF 4.694)
8. P. Mahalapbutr, K. Thitinanthavet, T. kedkham, N. Huy, T. Le,S. Dokmaisrijan, L. Huynh, N. Kungwan, T. Rungrotmongkol*, A theoretical study on the molecular encapsulation of luteolin and pinocembrin with various derivatized beta-cyclodextrins, Journal of Molecular Structure, 2019, 1180, 480-490. (IF 2.120)
9. P. Mahalapbutr, B. Nutho, P. Wolschann, N. Kungwan, T. Rungrotmongkol*, Molecular insights into inclusion complexes of mansonone E and H enantiomers with various β-cyclodextrins, Journal of Molecular Graphics and Modeling, 2018, 79, 72-80. (IF 1.863)
10. P. Mahalapbutr, P. Chusuth, N. Kungwan, W. Chavasiri, P. Wolschann, T. Rungrotmongkol*, Molecular recognition of naphthoquinone-containing compounds against human DNA topoisomerase IIα ATPase domain: A Molecular Modeling Study, Journal of Molecular Liquids, 2017, 247, 374-385. (IF 4.561)
11. T. Somboon, P. Mahalapbutr, K. Sanachai, S. Hannongbua*, T. Rungrotmongkol*, Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease, Journal of Molecular Liquids, 2021, 322, 114999. (IF 5.065)
12. K. Karnchanapandh, C. Hanpaibool, P. Mahalapbutr, T. Rungrotmongkol*, Source of oseltamivir resistance due tosingle E276D, R292K, and double E276D/R292K mutations in H10N4 influenza neuraminidase, Journal of Molecular Liquids, 2021, 115294. (IF 5.065)
13. K. Verma, P. Mahalapbutr, A. Auepattanapong, O.Khaikate, C. Kuhakarn, K. Takahashi, T. Rungrotmongkol*, Molecular dynamics simulations of sulfone derivatives in complex with DNA topoisomerase IIα ATPase domain, Journal of Biomolecular Structure and Dynamics, 2020, Article in press (DOI: 10.1080/07391102.2020.1831961). (IF 3.310)
14. J. Kammarabutr, P. Mahalapbutr, H. Okumura, P. Wolschann, T. Rungrotmongkol, Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase, Journal of Biomolecular Structure and Dynamics, 2020, Article in press, doi: 10.1080/07391102.2020. (IF 3.310)
15. N. Pradubyat, P. Mahalapbutr, C. Mitrpan, T. Elmitwali, A. Giannoudis, C. Palmieri, W. Ketchart*, 1’ acetoxychavicol acetate targets urokinase plasminogen activator and basic fibroblast growth factor repressing proliferation and invasion of endocrine-resistant breast cancer cells, Planta Medica, 2020, Accepted. (IF 2.74)
16. K. Sanachai, P. Mahalapbutr, K. Choowongkomon, P. Wolschann, T. Rungrotmongkol*, Insights into the binding recognition and susceptibility of tofacitinib toward Janus kinases, ACS Omega, 2020, 5 (1), 369-377. (IF 2.584)
17. S. Kitdumrongthum, S. Reabroi, K. Suksen, P. Tuchinda, B. Munyoo, P. Mahalapbutr, T. Rungrotmongkol, P. Ounjai, A. Chairoungdua*, Inhibition of topoisomerase IIα and induction of DNA damage in cholangiocarcinoma cells by altholactone and its halogenated benzoate derivatives, Biomedicine and Pharmacotherapy, 2020, 127, 110149. (IF 3.743)
18. H. Soe, P. Mahalapbutr, N. Kongtaworn, T. Rungrotmongkol, S. Chamni, P. Jansook*, The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state, Carbohydrate Research, 2020, 108190. (IF 1.841)
19. P. Chonsut, P. Mahalapbutr, W. Chavasiri, P. Wonganan, W. Ketchart*, Ethoxy mansonone G as an anti-cancer agent in estrogen receptor positive and endocrine-resistant breast cancer, Journal of Pharmacy and Pharmacology, 2019, 71(12), 1839-1853. (IF 2.390)
20. J. Kammarabutr, P. Mahalapbutr, B. Nutho, N. Kungwan, T. Rungrotmongkol*, Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation, Journal of Molecular Graphics and Modelling, 2019, 89, 122-130. (IF 1.863)

Ad Hoc Journal Reviewer

1. Biochimie (IF 3.362, Elsevier)
2. Journal of Biomolecular Structure and Dynamics (IF 3.220, Taylor and Francis)
3. Medical Science Monitor (IF 1.980, Medical Science International Publishing)